# Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

> **NCT01515774** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Mirapex ER

## Key facts

- **NCT ID:** NCT01515774
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515774, "Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01515774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*